1. Introduction
===============

Cardiovascular diseases (CVD) are the largest cause of morbidity and mortality in the world. It is expected that about 25 million people will die due from CVD, especially ischemic heart disease and stroke, in 2030 \[[@B1-nutrients-07-04124]\]. Atherosclerosis is the main cause of cardiovascular diseases, and inflammation is well known to be linked to the development and progression of atherosclerosis \[[@B2-nutrients-07-04124]\]. Inflammation is involved in all phases of the atherothrombotic process. Not only does promote the onset of the vascular injury, but it also leads to the progression and development of atherothrombotic complications that are responsible for acute ischemic clinical events \[[@B3-nutrients-07-04124]\].

The relationship between diet and CVDs is well recognized. Diet has been shown to modulate inflammation \[[@B4-nutrients-07-04124],[@B5-nutrients-07-04124]\]. The Western dietary pattern, rich in red meat, refined grains, butter, processed meat, high-fat dairy products, sweets and desserts, potatoes, eggs, hydrogenated fats and sugared-sweetened beverages, has been associated with increased levels of inflammatory and other intermediate markers of CVD \[[@B4-nutrients-07-04124]\]. On the other hand, a Mediterranean dietary pattern (rich in olive oil, nuts, fruits and vegetables, whole grains and fish, moderate intake of alcohol, but low in red/processed meat, refined grains and sweets) has been reported to be associated with lower levels of inflammation and a lower risk of CVD \[[@B6-nutrients-07-04124],[@B7-nutrients-07-04124],[@B8-nutrients-07-04124],[@B9-nutrients-07-04124],[@B10-nutrients-07-04124]\].

Dietary patterns have been studied because they better describe the eating habits actually followed by a population and they take into account possible interactions between nutrients. Food patterns also may overcome potential confounding by specific nutrients or foods, and avoid the problem of collinearity between foods. However, the large variety of foods available in an average diet results in a large number of nutrients that can interact with each other, producing synergistic or antagonistic effects. Overall dietary scores allow a better assessment of the dietary pattern. In this context, the Dietary Inflammatory Index (DII) was proposed to assess the inflammatory effect of an individual's diet \[[@B11-nutrients-07-04124]\]. The DII represents a literature-derived, population-based dietary score summarizing the effect of dietary parameters on six inflammatory biomarkers according to a comprehensive review of the published literature.

In addition to higher levels of inflammatory biomarkers, subjects consuming a pro-inflammatory diet, as represented by a higher DII, had increased indices of general and abdominal obesity, as previously reported \[[@B12-nutrients-07-04124]\]. The purpose of the present study was to prospectively examine the association between the DII values and the incidence of CVD during the follow-up interventions in the PREDIMED study.

2. Materials and Methods
========================

The PREDIMED study (Prevención con Dieta Mediterránea) is a parallel group, multicenter, randomized trial conducted in Spain. The design, methods, and objectives of the PREDIMED study have been reported previously \[[@B13-nutrients-07-04124],[@B14-nutrients-07-04124]\].

2.1. Participants
-----------------

Briefly, participants were men (55 to 80 years of age) and women (60 to 80 years of age) with high cardiovascular risk, but with no history of clinical cardiovascular disease at enrollment. They were randomly assigned to one of three diets (a Mediterranean diet supplemented with extra-virgin olive oil, a Mediterranean diet supplemented with nuts, or a low-fat diet in the control group). Participants received individual and group educational sessions on a quarterly basis-, and, depending on the group assignment, free provision of extra-virgin olive oil, mixed nuts, or small nonfood gifts.

The protocol of the study was approved by the institutional review boards at all study locations.

The study began on 1 October 2003, and though the follow-up was planned to last for 6 years on average, on advice by the Data and Safety Monitoring Board, the trial was stopped early after a median follow-up of 4.8 years, on the basis of the results of the fourth interim analysis, which showed early evidence of benefit \[[@B15-nutrients-07-04124]\].

2.2. Data Collection and Outcomes
---------------------------------

A 137-item validated food-frequency questionnaire was administered on a yearly basis. Biomarkers of compliance were measured in random subsamples of participants at one, three and five years and demonstrated adequate compliance with the intended diet in the intervention groups \[[@B15-nutrients-07-04124],[@B16-nutrients-07-04124]\].

The primary end point was a composite of myocardial infarction, stroke, and death from cardiovascular causes. Secondary end-points were stroke, myocardial infarction, death from cardiovascular causes and death from any cause. Contacts with participants, contacts with family physicians, a yearly review of medical records, and consultation of the National Death Index were the sources used to identify primary and secondary end points. The medical records related to end points were examined by the end-point adjudication committee, whose members were unaware of the study-group assignments. Only end points that were confirmed by the adjudication committee and had occurred between 1 October 2003, and 1 December 2010, were included in the analysis.

The information derived from the 137-item Food-Frequency Questionnaire (FFQ) was used to calculate Dietary Inflammatory Index (DII) scores. The procedure used to calculate the DII scores for all subjects, from the FFQ, was described elsewhere \[[@B11-nutrients-07-04124]\]. Briefly, the DII was derived after a literature review from 1950 to 2010, including all articles that had assessed the role of whole foods and dietary constituents on interleukins (IL-1B, IL-4, IL-6, IL-10), Tumor Necrosis Factor-alpha and highly sensitive C-Reactive Protein (CRP). Overall DII scores for each participant represent the sum of each of the DII components in relation to the comparison global diet database. The DII score characterizes an individual's diet on a continuum from maximally anti-inflammatory (negative values, lower quartiles) to maximally pro-inflammatory (positive values, higher quartiles) \[[@B17-nutrients-07-04124]\].

2.3. Statistical Analysis
-------------------------

Participants were categorized into quartiles based on DII scores. Quartile sample size to achieve sufficient power was estimated assuming a comparison between extreme quartiles with two-tailed alpha error = 0.05, relative risk = 0.60, absolute risk (cumulative incidence) = 4% for two-quartile average (3% in the lowest *versus* 5% in the highest quartile), and statistical power = 0.80. Under these assumptions, the required sample size in each of the two extreme quartiles was 1605, which is covered with the number of participants in each of our extreme quartiles. Participants with total energy intake outside of predefined limits (800 and 4000 Kcal day^−1^ for men and 500 and 3500 Kcal day^−1^ for women) were excluded ([Figure 1](#nutrients-07-04124-f001){ref-type="fig"}).

Time-to-event data were analyzed using Cox regression models. The time of the event was defined as the number of days from recruitment to the last visit, the diagnosis of the clinical cardiovascular event, or death (whichever came first) as determined by the external board of adjudicators of clinical events. Cox proportional hazard analyses were conducted with stratification for center and intervention group in all models. After a crude analysis, we fitted a model adjusted for sex and age. In a subsequent model we additionally adjusted for the major risk factors of cardiovascular disease. Robust standard errors were used. All p values were two-tailed. Statistical significance was set at the conventional 0.05 level.

![Flow chart of participant selection.](nutrients-07-04124-g001){#nutrients-07-04124-f001}

3. Results
==========

After exclusions, we included 7216 of the 7447 participants of the PREDIMED trial in our analysis ([Figure 1](#nutrients-07-04124-f001){ref-type="fig"}). Among them, we observed 277 cardiovascular clinical events during 31,040 persons-years of follow-up.

[Table 1](#nutrients-07-04124-t001){ref-type="table"} shows the main baseline characteristics of participants according to DII quartiles. The mean age of participants was 67.0 (SD: 6.2) years, and 57.4% were women. Participants in the higher quartiles of the DII had lower levels of leisure-time physical activity but also lower levels of dyslipidemia at baseline. The educational level was higher in participants whose values of the DII were lower, whereas their total energy intake was considerably higher. Carbohydrate intake, Polyunsaturated fatty acid (PUFA) intake, fiber intake and total intake of alcohol of participants in the lowest quartile of the DII were higher than in participants in the highest quartile.
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###### 

Description of main characteristics of participants according to the dietary inflammatory index score, the PREDIMED (Prevención con Dieta Mediterránea) trial, 2003--2010.

  Variables                                              Quartiles of Dietary Inflammatory Index (DII) (a Higher Value Implies Higher Inflammatory Potential)                             
  ------------------------------------------------------ ------------------------------------------------------------------------------------------------------ ------------ ------------ ------------
                                                         Q1                                                                                                     Q2           Q3           Q4
  DII, median                                            −2.46                                                                                                  −1.34        −0.32        1.17
  Number                                                 1804                                                                                                   1804         1804         1804
  Age, year                                              66 (6)                                                                                                 67 (6)       67 (6)       68 (6)
  Sex (% Women),                                         55                                                                                                     57           58           60
  Family history of early CHD, %                         23                                                                                                     24           22           20
  Hypertension, %                                        81                                                                                                     83           84           83
  Dyslipidemia, %                                        76                                                                                                     72           71           69
  Diabetes, %                                            48                                                                                                     46           49           52
  Smoking, %                                                                                                                                                                              
  Never                                                  61                                                                                                     60           62           63
  Former                                                 26                                                                                                     26           24           22
  Current                                                13                                                                                                     14           14           15
  Body mass index, kg m^−2^                              29.6 (3.9)                                                                                             30.0 (3.9)   30.0 (3.8)   30.0 (3.8)
  Waist-to-height ratio                                  0.6 (0.1)                                                                                              0.6 (0.1)    0.6 (0.1)    0.6 (0.1)
  Physical activity, METS-min day^−1^                    270 (279)                                                                                              237 (241)    224 (223)    194 (199)
  Marital status, %                                                                                                                                                                       
  Single                                                 4                                                                                                      5            4            5
  Married                                                81                                                                                                     75           77           72
  Widowed                                                13                                                                                                     18           16           19
  Other                                                  2                                                                                                      3            4            3
  Educational level, %                                                                                                                                                                    
  Primary education or less                              74                                                                                                     78           79           80
  Secondary education                                    17                                                                                                     15           15           14
  College or higher                                      9                                                                                                      7            6            6
  Total energy intake, kcal day^−1^                      2542 (535)                                                                                             2347 (512)   2146 (460)   1909 (450)
  Alcohol intake, g day^−1^                              10 (15)                                                                                                8 (14)       8 (14)       7 (13)
  Protein intake, % energy                               16.7 (2.7)                                                                                             16.5 (2.7)   16.7 (2.8)   16.7 (3.0)
  Carbohydrate intake, % energy                          42.5 (7.1)                                                                                             42.4 (6.9)   41.8 (7.1)   40.5 (7.3)
  Total fat intake, % energy                             38 (7)                                                                                                 39 (7)       39 (7)       40 (7)
  Saturated, % energy                                    9 (2)                                                                                                  10 (2)       10 (2)       11 (2)
  Monounsaturated, % energy                              18 (5)                                                                                                 19 (4)       20 (4)       21 (5)
  Polyunsaturated, % energy                              7 (2)                                                                                                  6 (2)        6 (2)        6 (2)
  Fiber, g day^−1^                                       34 (9)                                                                                                 27 (6)       23 (5)       17 (4)
  Adherence to the Mediterranean diet (0 to 14 points)   10 (2)                                                                                                 9 (2)        8 (2)        8 (2)

All values are means (standard deviations), unless otherwise stated. When we adjusted for sex and age we did observe significant differences (*p* \< 0.001) in age- and sex-adjusted average body mass index (BMI) across categories of the Dietary Inflammatory Index (DII). Participants in the highest category of the DII exhibited a significantly higher average BMI (30.23, 95% CI: 30.05--30.41) than those in the lowest quartile (BMI = 29.65, 95% confidence interval (CI): 29.47--29.83) after accounting for differences in sex and age. A similar direct and significant age-, and sex-adjusted association was observed for the waist-to-height ratio.

Adherence to the Mediterranean diet was inversely associated with the DII, being higher in the lowest DII quartile. However, the magnitude of the observed difference in Mediterranean diet adherence between extreme DII quartiles was not large.

[Table 2](#nutrients-07-04124-t002){ref-type="table"} shows the hazard ratios (95% CI) for the risk of CVD, according to quartiles of the DII stratified by center and intervention group. When we adjusted for sex and age, the linear trend tests were statistically significant. Linear trend tests remained statistically significant (*p* \< 0.05) after further adjustments for additional potential confounders. When we excluded events occurring within the first year of follow-up, we observed an even a stronger association with multivariable-adjusted HR above 1.90 for the two upper quartiles.

When we assessed the association between the DII and the incidence of CVD using the DII as a continuous variable (measured in standard deviation units), we observed that for each additional increase of 1 standard deviation in the DII, there was a 22% relative increase in the risk of CVD (95% CI: 6% to 40%) after multivariable adjustment.

Results were similar when we repeated the statistical analyses using quintiles instead of quartiles of adherence to the DII as the relevant exposure (data not shown, but available on request). There was no statistically significant interaction between the intervention arms (Mediterranean diet supplemented with either extra-virgin olive oil or Mediterranean diet supplemented with mixed nuts) and the DII. This indicates that the association between a more pro-inflammatory diet and a higher risk of CVD was fairly homogeneous across the three arms of the trial.

[Figure 2](#nutrients-07-04124-f002){ref-type="fig"} shows the incidence of cardiovascular disease according to tertiles of the DII. Participants in the highest tertile of the DII (the most pro-inflammatory diet) had a significantly higher incidence of the composite cardiovascular end-point when compared with the lowest tertile.

[Figure 3](#nutrients-07-04124-f003){ref-type="fig"} shows the cross-classification according to both intervention groups and the control group and to levels of DII dichotomized by the median of DII. The lowest risk of CVD was found in participants allocated to an active intervention with the Mediterranean diet and with low baseline values of the DII (representing a baseline anti-inflammatory dietary pattern), whereas the highest risk was observed in participants with a higher pro-inflammatory diet and allocated to the control group. Intermediate values of risk were found for participants in the control group with anti-inflammatory diets at baseline and in participants in the active intervention group with pro-inflammatory diets at baseline.

4. Discussion
=============

This study provided evidence of a direct prospective association between increased diet-associated inflammation, indicated by a higher DII, and a higher risk of cardiovascular disease. The relationship showed a strongly linear, dose-response trend. This is consistent with the results reported by Ruiz-Canela *et al.*, in this same cohort showing that a higher DII was associated with higher levels of general obesity and abdominal obesity, after controlling for the effect that adherence to a MeDiet had on inflammation \[[@B12-nutrients-07-04124]\]. Three previous reports have shown a positive relationship between a higher DII and inflammation \[[@B18-nutrients-07-04124],[@B19-nutrients-07-04124],[@B20-nutrients-07-04124]\].
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###### 

Hazard ratios (95% confidence interval) for the risk of cardiovascular disease, according to the dietary inflammatory index, the PREDIMED trial, 2003--2010.

  Hazard Ratios (HR)                               Quartiles of Adherence to the Dietary Inflammatory Index                                                                
  ------------------------------------------------ ---------------------------------------------------------- -------------------- ------------------- ------------------- -------
  Cases/person-years                               49/7641                                                    64/7755              85/7684             79/7960             
  Crude HR                                         1 (ref)                                                    1.32 (0.91--1.92)    1.84 (1.29--2.63)   1.68 (1.16--2.43)   0.003
  Adjusted for age and sex HR                      1 (ref)                                                    1.41 (0.96--2.06)    1.87 (1.29--2.69)   1.76 (1.21--2.57)   0.002
  Multivariable adjusted HR ^1^                    1 (ref)                                                    1.42 (0.97--2.09)    1.85 (1.27--2.71)   1.73 (1.15--2.60)   0.008
  After excluding cases with follow-up \< 1 year   36/7633                                                    58/7752              73/7678             63/7951             
  Crude HR                                         1 (ref)                                                    1.62 (1.071--2.48)   2.16 (1.43--3.24)   1.83 (1.20--2.78)   0.005
  Adjusted for age and sex HR                      1 (ref)                                                    1.75 (1.14--2.68)    2.21 (1.46--3.35)   1.93 (1.26--2.97)   0.004
  Multivariable adjusted HR ^1^                    1 (ref.)                                                   1.76 (1.14--2.70)    2.22 (1.45--3.41)   1.90 (1.20--3.01)   0.012

1: adjusted for age and sex, overweight/obesity, waist-to-height ratio, total energy intake (quartiles), smoking status (3 categories), diabetes, hypertension, dyslipidemia, family history of premature cardiovascular disease, physical activity (quartiles) and educational level, and stratified by intervention group and center. All models were stratified by intervention group and center.

![Incidence of cardiovascular disease according to tertiles of the dietary inflammatory index, the PREDIMED trial, 2003--2010.](nutrients-07-04124-g002){#nutrients-07-04124-f002}

![Cross-classification according to the PREDIMED intervention (both Mediterranean diet groups merged together) and to levels of the Dietary Inflammatory Index (DII) dichotomized by the median of the DII. Multivariable-adjusted Hazard Ratios for the primary end-point (a composite of myocardial infarction, stroke or cardiovascular death).](nutrients-07-04124-g003){#nutrients-07-04124-f003}

An interesting finding in our study is that we observed a strengthening of the association when we excluded events occurring within the first year of follow-up. This is consistent with our initial hypothesis because very early events may be related to other previous exposures and not necessarily to the DII measured at baseline, *i.e.*, immediately before those events. As it would be unlikely to assume a very short induction period for the association between the DII and the occurrence of new CVD clinical events, our expectation was to find a stronger association when very early events were removed.

The association between DII scores, obtained from a food-frequency questionnaire (FFQ), and serum levels of inflammatory biomarkers measured in other cohorts have been reported \[[@B18-nutrients-07-04124],[@B19-nutrients-07-04124],[@B20-nutrients-07-04124],[@B21-nutrients-07-04124]\]. However, we did not measure these biomarkers in all participants in our cohort and therefore we were not able to assess this association. One advantage of using the DII instead of biomarkers is that we could comment on the direct association between dietary exposures and clinical events. Additional advantages include reduced cost and the avoidance of blood collection and analytical determinations. By using a simple, inexpensive, noninvasive tool (the FFQ)we were able to assess the role of diet associated inflammation without relying on an intermediate measure. .

Diet has consistently been shown to regulate inflammation \[[@B22-nutrients-07-04124],[@B23-nutrients-07-04124],[@B24-nutrients-07-04124],[@B25-nutrients-07-04124]\]. Specifically, a modified version of the DII has recently been shown to predict a higher summary score for inflammation according to a combination of six inflammatory serum biomarkers, and to predict markers of glucose metabolism \[[@B26-nutrients-07-04124]\]. However, a study from Luxembourg reported no association between the same new, improved DII that we used in this study and diastolic blood pressure, CRP, lipids, and glycemic biomarkers \[[@B27-nutrients-07-04124]\].

In previous analyses of the PREDIMED study, an increased adherence to the Mediterranean diet had been shown to be associated with lower levels of CRP. The PREDIMED study also has found lower levels of other inflammatory and immune biomarkers associated with better adherence to the Mediterranean diet, a higher consumption of some of the typical Mediterranean foods or with the interventions conducted in this trial \[[@B5-nutrients-07-04124],[@B28-nutrients-07-04124],[@B29-nutrients-07-04124],[@B30-nutrients-07-04124],[@B31-nutrients-07-04124]\]. The inverse association between the DII and adherence to the Mediterranean diet observed in our data is consistent with the predicted association between DII and CRP showed by Shivappa *et al.*, in the SEASONS and the Asklepos studies \[[@B18-nutrients-07-04124],[@B19-nutrients-07-04124]\] and by Wirth *et al.*, among police officers \[[@B32-nutrients-07-04124]\]. Other studies have reported that higher adherence to the Mediterranean diet is associated with decreased levels of inflammatory biomarkers (including CRP, interleukin-6, and intracellular adhesion molecule-1) as summarized by a recent meta-analysis \[[@B33-nutrients-07-04124]\]. This consistency in findings provides further strength to our results.

Additional strengths of our study are that: (a) we used a prospective follow-up design to ascertain the occurrence of clinical events; (b) our analyses were not mainly based in intermediate biomarkers changes but provided direct evidence of an association with final hard clinical events; (c) we were able to control for a wide array of potentially confounding factors and to assess the combined effect of the baseline inflammatory potential of the diet and the dietary intervention.

Some limitations need also to be acknowledged. Not all foods of the FFQ were included in the calculation of the DII. The DII was built using articles that examined the effect of individual nutrients in relation to intermediate biomarkers, but it did not assess the effect of the overall dietary pattern intake on these biomarkers. As the DII was created depending on the published literature, there could be findings that were not included or not published because of null findings (*i.e.*, publication bias may have occurred). In any case, the DII was created based on an extensive literature search and did not take into account only certain nutrients or foods but tried to assess many of them, and, therefore, in this way did assess the whole diet. Also, there were a large number of null results reported in the reviewed literature. Other limitations are related to the generalizability of our findings. Because all study participants lived in a Mediterranean country and were at high cardiovascular risk, extrapolating our results requires replication in other settings and populations. In any case, the fact is that participants in the PREDIMED study, despite being high-risk subjects, had an average lower DII (−0.75, SD: 1.53) than participants in previous studies that have assessed the inflammatory capacity of the diet using the DII (+0.84 SD: 1.99) \[[@B19-nutrients-07-04124]\].

5. Conclusions
==============

In summary, we found for the first time prospective direct evidence that diets with higher pro-inflammatory potential were directly associated with a increased likelihood of developing clinical cardiovascular events. This direct association was strong, gradual, and consistent across different methods of categorizing the dietary inflammatory capacity and showed a linear dose-response trend.
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